Mitral Stenosis Caused by an Amplatzer Occluder Device Used to Treat a Paravalvular Leak
Division of Cardiology, University of Virginia Health System, Charlottesville, Virginia 22908, USA.The Annals of thoracic surgery (Impact Factor: 3.85). 06/2012; 93(6):2058-60. DOI: 10.1016/j.athoracsur.2011.11.064
Paravalvular leaks following valve replacement can result in heart failure and hemolysis. Surgical intervention is the treatment of choice, but it carries substantial risk of morbidity and mortality. Percutaneous techniques using devices designed for congenital heart disease are increasingly applied to the treatment of paravalvular leaks. We present the case of a mitral paravalvular leak treated with an Amplatzer occluder device. Unfortunately, the device occluded flow through the mitral valve, resulting in symptomatic mitral stenosis requiring surgical intervention.
- [Show abstract] [Hide abstract]
ABSTRACT: A large mitral paravalvular leak in a 63-year-old patient was closed by percutaneous placement of 2 Amplatzer Septal Occluder (AGA Medical Corporation, Plymouth, MN) devices. The patient had a residual paravalvular leak and subsequently developed infective endocarditis that was successfully treated by removal of all hardware and implantation of a new valve. Transcatheter treatment of paravalvular leaks may be useful in select patients who are poor candidates for open surgery; however, one must be aware of the potential complications. This report underscores the risk of device infection that may be increased if there is turbulence related to residual paravalvular leaks.
Article: [Mitral stenosis][Show abstract] [Hide abstract]
ABSTRACT: This paper deals with mitral stenosis in the light of current knowledge. Currently, defect is in developed countries very rare (about 10% of defects). Its etiology has changed over the period of time mainly due to decline in rheumatic fever. Review discusses clinical, echocardiographic and catheterization findings, as well as treatment and prognosis. Key words: echocardiography in mitral stenosis - mitral stenosis - mitral valve replacement.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.